Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1979 1
1982 1
1983 1
1986 2
1987 1
1988 1
1989 2
1990 2
1991 3
1992 7
1993 6
1994 7
1995 10
1996 3
1997 12
1998 11
1999 17
2000 24
2001 24
2002 25
2003 35
2004 44
2005 67
2006 101
2007 105
2008 130
2009 152
2010 182
2011 193
2012 221
2013 220
2014 203
2015 262
2016 239
2017 258
2018 237
2019 283
2020 304
2021 332
2022 149
Text availability
Article attribute
Article type
Publication date

Search Results

3,348 results
Results by year
Filters applied: . Clear all
Page 1
Biliary tract cancer.
Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Valle JW, et al. Among authors: oh dy. Lancet. 2021 Jan 30;397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7. Lancet. 2021. PMID: 33516341 Review.
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Abou-Alfa GK, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DV, Borad MJ, Bridgewater J, Harris WP, Murphy AG, Oh DY, Whisenant J, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Fan B, Wu B, Chamberlain CX, Jiang L, Gliser C, Pandya SS, Valle JW, Zhu AX. Abou-Alfa GK, et al. Among authors: oh dy. Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13. Lancet Oncol. 2020. PMID: 32416072 Free PMC article. Clinical Trial.
Toward a better understanding of T cells in cancer.
Oh DY, Fong L, Newell EW, Turk MJ, Chi H, Chang HY, Satpathy AT, Fairfax B, Silva-Santos B, Lantz O. Oh DY, et al. Cancer Cell. 2021 Dec 13;39(12):1549-1552. doi: 10.1016/j.ccell.2021.11.010. Cancer Cell. 2021. PMID: 34906313
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.
Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, Sa M, Kim AR, Joo EJ, Ahn JY, Kim JH, Song KH, Kim ES, Oh DH, Ahn MY, Choi HK, Jeon JH, Choi JP, Kim HB, Kim YK, Park SH, Choi WS, Choi JY, Peck KR, Shin EC. Rha MS, et al. Among authors: oh dh. Immunity. 2021 Jan 12;54(1):44-52.e3. doi: 10.1016/j.immuni.2020.12.002. Epub 2020 Dec 14. Immunity. 2021. PMID: 33338412 Free PMC article.
Receptor Switching in Newly Evolved Adeno-associated Viruses.
Havlik LP, Das A, Mietzsch M, Oh DK, Ark J, McKenna R, Agbandje-McKenna M, Asokan A. Havlik LP, et al. Among authors: oh dk. J Virol. 2021 Sep 9;95(19):e0058721. doi: 10.1128/JVI.00587-21. Epub 2021 Sep 9. J Virol. 2021. PMID: 34232726 Free PMC article.
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J, Cleary JM, Catenacci DVT, Borad MJ, Bridgewater JA, Harris WP, Murphy AG, Oh DY, Whisenant JR, Lowery MA, Goyal L, Shroff RT, El-Khoueiry AB, Chamberlain CX, Aguado-Fraile E, Choe S, Wu B, Liu H, Gliser C, Pandya SS, Valle JW, Abou-Alfa GK. Zhu AX, et al. Among authors: oh dy. JAMA Oncol. 2021 Nov 1;7(11):1669-1677. doi: 10.1001/jamaoncol.2021.3836. JAMA Oncol. 2021. PMID: 34554208 Free PMC article. Clinical Trial.
Perivascular mesenchymal cells control adipose-tissue macrophage accrual in obesity.
Shan B, Shao M, Zhang Q, Hepler C, Paschoal VA, Barnes SD, Vishvanath L, An YA, Jia L, Malladi VS, Strand DW, Gupta OT, Elmquist JK, Oh D, Gupta RK. Shan B, et al. Among authors: oh d. Nat Metab. 2020 Nov;2(11):1332-1349. doi: 10.1038/s42255-020-00301-7. Epub 2020 Nov 2. Nat Metab. 2020. PMID: 33139957 Free PMC article.
3,348 results